Asia Pacific CRISPR Market- Segmentation, Market Share, Size, and Forecast to 2024

Asia Pacific CRISPR Market- Segmentation, Market Share, Size, and Forecast to 2024

$6,000

SKU: 1315 Categories: ,
  • Report Description
  • Table of Content
  • Request for Sample

Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) market witnessing healthy growth forecast at CAGR XX% for period 2017-2024. The market growth is fuelled by increasing investment in animal and plant breeding, high incidence of chronic diseases, rise in life science R&D spending, new improved bioinformatics tools, demand for precise gene editing tools, thriving biotechnology sector, increasing healthcare spending and growing demand for personalized medical interventions. Off target effects, other alternative gene editing tools, inadequate research funding, ethical research concerns and limited awareness would hamper market growth for the forecasted period. Since 2013, CRISPR has changed genetic research, opening new possibilities for disease treatment and crop health. The number of patents and publications of research relevant to CRISPR has increased significantly. A study from University of California, globally on CRISPR showed that the number of patents & research publications on research increased from 71 per month in 2012 to over 100 per month by the end of 2016.

 

Asia Pacific Life Science industry is in a constant pursuit of attracting investment and increase competitiveness to foreign counterparts especially in biotechnology domain. Asia Pacific accounts for approximately 20% of global biotechnology market in 2018, according to OBRC analysis. Furthermore, net revenue of biotechnology sector is anticipated to increase from approximately $88 billion in 2018 to around $218 billion by 2025. Rising incidences of chronic & lifestyle diseases, aging population, collaborative research and rise in healthcare expenditure have bolstered life science (biotechnology) sector growth for the forecast period. Government and private institutions are looking forward to adopt collaborative research to encourage R&D ecosystem within life sector. For instance, Government of India in FY 2017, encouraged Public Private Partnerships (PPP) for R&D projects especially in biotechnology through schemes like ‘Centre for Excellence in Biotechnology’ (CEIB). Schemes & incentives for research are likely to encourage investment in APAC CRISPR market. Thriving biotechnology market has paved way towards growth for gene editing market across the globe aiding demand for CRISPR products.

Asia Pacific CRISPR market report is segmented on the basis of products, application, and end user. The product segment is bifurcated further as design tools, plasmid & vectors, Cas9 nuclease & gRNA, and delivery systems. Cas9 nuclease & gRNA holds largest market share for 2018 and is anticipated to grow with highest CAGR for the forecast period. Simplicity and efficiency makes Cas9/gRNA an effective tool for gene editing compared to other products. Application segment is classified as cell line engineering, CRISPR plasmid, genetic engineering, genetically modified organisms & crops, genome editing, gene database/library, and human stem cells. End-user segment is divided as academic institutes, biotechnology companies, pharmaceutical companies, and research & development institutes. Biotechnology companies are the fastest growing end-user segment for the forecasted period 2017-2024. Rising number of PPPs and investment friendly environment aids in research & development within biotechnology firms in Asia Pacific.

China is the largest market for CRISPR within Asia Pacific. CRISPR market growth in China is driven by factors like rising R&D investment, increasing incidence of chronic diseases, and changing government & regulatory policies. Government of China in 13th five-year plan made research & innovation a priority. As per the plan, Government of China is looking forward to set up regional life science research parks across East China by proving tax incentives and funding for start-ups. Other key Asia Pacific CRISPR markets include India, Japan, South Korea, and Australia.

Key players of Asia Pacific CRISPR market are Caribou Biosciences Inc., Intellia Therapeutics Inc., Cellectis Bioresearch SAS., Crispr Therapeutics AG., Integrated DNA Technologies., Genscript., Editas Medicine., Novartis International AG., Transposagen Biopharmaceuticals Inc., Sigma-Aldrich Inc., Horizon Discovery Inc., Precision Bioscience., Thermo Fischer Scientific Inc.. Collaboration, partnerships, mergers & acquisition and patents are some of the strategies being adopted by key players within the market. For example, Cellectis and Allogene Therapeutics Ltd announced their intent of continuing the partnership for CAR-T therapy immunotherapies for oncology. The agreement initially signed in 2014, will be continued further till 2020 aiding research circumventing cancer immunotherapy. Together both Cellectis and Allogene Therapeutics Ltd. is looking forward for resource sharing and profit sharing from research. Similarly, in 2017, Intellia Therapeutics Ltd. announced grant of patent for CRISPR/Cas Genome editing by China’s State Intellectual Property Office (SIPO). The patent include claim covering varied methods for gene editing in cellular and non-cellular settings. SIPO’s decision, further expands Intellia Therapeutics Ltd. intellectual and patent portfolio.

 

 

  1. INTRODUCTION
    • EXECUTIVE SUMMARY
    • ESTIMATION METHODOLOGY
  2. MARKET OVERVIEW
    • MARKET DEFINITION AND SCOPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • PORTER’S 5 FORCE MODEL
    • KEY MARKET TRENDS
      • PIPELINE ANALYSIS
      • R & D SCENARIO
      • REGULATORY FRAMEWORK
    • PARAMETRIC ANALYSIS
    • KEY MARKET INSIGHTS
      • TOP 3 EMERGING COUNTRIES
      • TOP 3 REVENUE GENERATING SEGMENTS
      • TOP 3 EMERGING SEGMENTS
    • COMPETITIVE INTELLIGENCE
      • MARKET SHARE ANALYSIS
      • TOP WINNING STRATEGIES
      • CASE STUDY: TOP COMPETITIVE MOVES
    • STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
      • INVESTMENT OPPORTUNITIES BY REGIONS
      • OPPORTUNITIES IN EMERGING PRODUCTSS
      • INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
  1. MARKET DETERMINANTS
    • MARKET DRIVER
      • INCREASING INVESTMENT IN ANIMAL AND PLANT BREEDING
      • HIGH INCIDENCE OF CHRONIC DISEASES
      • RISE IN LIFE SCIENCE R&D SPENDING
      • NEW IMPROVED BIOINFORMATICS TOOLS
      • DEMAND FOR PRECISE GENE EDITING TOOLS
      • THRIVING BIOTECHNOLOGY SECTOR
      • INCREASING HEALTHCARE SPENDING
      • GROWING DEMAND FOR PERSONALIZED MEDICINE INTERVENTIONS
    • MARKET RESTRAINTS
      • OFF TARGET EFFECTS
      • ETHICAL RESEARCH CONCERNS
    • MARKET OPPORTUNITIES
      • EMERGING MARKETS LIKE INDIA AND CHINA
    • MARKET CHALLENGES
      • RISING COMPETITION
      • INADEQUATE RESEARCH FUNDING
      • LIMITED AWARENESS OF CRISPR TOOLS
  1. MARKET SEGMENTATION
    • APAC CRISPR MARKET BY PRODUCTS 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY DESIGN TOOLS 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY PLASMID & VECTORS 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY CAS 9 NUCLEASE & GRNA2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY DELIVERY SYSTEMS 2015-2024 ($ MILLION)
    • APAC CRISPR MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY CELL LINE ENGINEERING 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY CRISPR PLASMID 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY GENETIC ENGINEERING 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY GENETICALLY MODIFIED ORGANISMS & CROPS 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY GENOME EDITING 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY GENE DATABASE/LIBRARY 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY HUMAN STEM CELLS 2015-2024 ($ MILLION)
    • APAC CRISPR MARKET BY END USER 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY ACADEMIC INSTITUTES 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY BIOTECHNOLOGY COMPANIES 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY PHARMACEUTICAL COMPANIES 2015-2024 ($ MILLION)
      • APAC CRISPR MARKET BY RESEARCH & DEVELOPMENT INSTITUTES 2015-2024 ($ MILLION)
  1. APAC LEVEL SEGMENTATION
    • CHINA CRISPR MARKET 2015-2024 ($ MILLION)
    • INDIA CRISPR MARKET 2015-2024 ($ MILLION)
    • KOREA CRISPR MARKET 2015-2024 ($ MILLION)
    • JAPAN CRISPR MARKET 2015-2024 ($ MILLION)
    • AUSTRALIA CRISPR MARKET 2015-2024 ($ MILLION)
    • THAILAND CRISPR MARKET 2015-2024 ($ MILLION)
    • REST OF ASIA PACIFIC CRISPR MARKET 2015-2024 ($ MILLION)
  2. GLOBAL VS APAC MARKET “A COMPARATIVE STUDY”
    • DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • OPPORTUNITY MATRIX
    • GLOBAL VS. APAC MARKET
    • US VS. APAC MARKET
    • EUROPE VS. APAC MARKET
    • ROW VS. APAC MARKET
  3. COMPANY PROFILES
    • CARIBOU BIOSCIENCE INC.
    • INTELLIA THERAPEUTICS INC.
    • CELLECTIS BIORESEARCH SAS
    • CRISPR THERAPEUTICS AG
    • INTEGRATED DNA TECHNOLOGIES
    • GENSCRIPT
    • EDITAS MEDICINE
    • NOVARTIS INTERNATIONAL AG
    • TRANSPOSAGEN BIOPHARMACETUCALS INC.
    • SIGMA-ALDRICH INC.
    • HORIZON DISCOVERY INC.
    • PRECRISION BIOSCIENCE
    • THERMO FISCHER SCIENTIFIC INC.

 

LIST OF TABLES

  1. APAC CRISPR MARKET BY PRODUCTS 2015-2024 ($ MILLION)
  2. APAC CRISPR MARKET BY DESIGN TOOLS ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  3. APAC CRISPR MARKET BY PLASMID & VECTORS ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  4. APAC CRISPR MARKET BY CAS 9 NUCLEASE & GRNA ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  5. APAC CRISPR MARKET BY DELIVERY SYSTEM ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  6. APAC CRISPR MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
  7. APAC CRISPR MARKET BY CELL LINE ENGINEERING ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  8. APAC CRISPR MARKET BY CRISPR PLASMID ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  9. APAC CRISPR MARKET BY GENETIC ENGINEERING ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  10. APAC CRISPR MARKET BY GENETICALLY MODIFIED ORGANSIMS & CROPS ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  11. APAC CRISPR MARKET BY GENOME EDITING ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  12. APAC CRISPR MARKET BY GENE DATABASE/LIBRARY ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  13. APAC CRISPR MARKET BY HUMAN STEM CELLS ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  14. APAC CRISPR MARKET BY END USERS 2015-2024 ($ MILLION)
  15. APAC CRISPR MARKET BY ACADEMIC INSTITUTIONS ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  16. APAC CRISPR MARKET BY BIOTECHNOLOGY COMPANIES ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  17. APAC CRISPR MARKET BY PHARMACEUTICAL COMPANIES ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  18. APAC CRISPR MARKET BY RESEARCH & DEVELOPMENT INSTITUTES ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  19. APAC CRISPR MARKET ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  20. CHINA CRISPR MARKET BY PRODUCTS 2015-2024 ($ MILLION)
  21. CHINA CRISPR MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
  22. CHINA CRISPR MARKET BY END USERS 2015-2024 ($ MILLION)
  23. INDIA CRISPR MARKET BY PRODUCTS 2015-2024 ($ MILLION)
  24. INDIA CRISPR MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
  25. INDIA CRISPR MARKET BY END USERS 2015-2024 ($ MILLION)
  26. JAPAN CRISPR MARKET BY PRODUCTS 2015-2024 ($ MILLION)
  27. JAPAN CRISPR MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
  28. JAPAN CRISPR MARKET BY END USERS 2015-2024 ($ MILLION)
  29. AUSTRALIA CRISPR MARKET BY PRODUCTS 2015-2024 ($ MILLION)
  30. AUSTRALIA CRISPR MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
  31. AUSTRALIA CRISPR MARKET BY END USERS 2015-2024 ($ MILLION)
  32. THAILAND CRISPR MARKET BY PRODUCTS 2015-2024 ($ MILLION)
  33. THAILAND CRISPR MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
  34. THAILAND CRISPR MARKET BY END USERS 2015-2024 ($ MILLION)
  35. REST OF ASIA PACIFIC CRISPR MARKET BY PRODUCTS 2015-2024 ($ MILLION)
  36. REST OF ASIA PACIFIC CRISPR MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
  37. REST OF ASIA PACIFIC CRISPR MARKET BY END USERS 2015-2024 ($ MILLION)
  38. GLOBAL CRISPR MARKET BY REGION 2015-2024 ($ MILLION)
  39. GLOBAL CRISPR MARKET BY PRODUCTS 2015-2024 ($ MILLION)
  40. GLOBAL CRISPR MARKET BY DESIGN TOOLS ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  41. GLOBAL CRISPR MARKET BY PLASMID & VECTORS ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  42. GLOBAL CRISPR MARKET BY CAS 9 NUCLEASE & GRNA ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  43. GLOBAL CRISPR MARKET BY DELIVERY SYSTEM ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  44. GLOBAL CRISPR MARKET BY APPLICATIONS 2015-2024 ($ MILLION)
  45. GLOBAL CRISPR MARKET BY CELL LINE ENGINEERING ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  46. GLOBAL CRISPR MARKET BY CRISPR PLASMID ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  47. GLOBAL CRISPR MARKET BY GENETIC ENGINEERING ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  48. GLOBAL CRISPR MARKET BY GENETICALLY MODIFIED ORGANSIMS & CROPS ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  49. GLOBAL CRISPR MARKET BY GENOME EDITING ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  50. GLOBAL CRISPR MARKET BY GENE DATABASE/LIBRARY ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  51. GLOBAL CRISPR MARKET BY HUMAN STEM CELLS ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  52. GLOBAL CRISPR MARKET BY END USERS 2015-2024 ($ MILLION)
  53. GLOBAL CRISPR MARKET BY ACADEMIC INSTITUTIONS ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  54. GLOBAL CRISPR MARKET BY BIOTECHNOLOGY COMPANIES ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  55. GLOBAL CRISPR MARKET BY PHARMACEUTICAL COMPANIES ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  56. GLOBAL CRISPR MARKET BY RESEARCH & DEVELOPMENT INSTITUTES ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  57. NORTH AMERICA CRISPR MARKET ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  58. EUROPE CRISPR MARKET ACROSS GEOGRAPHY 2015-2024 ($ MILLION)
  59. ROW CRISPR MARKET ACROSS GEOGRAPHY 2015-2024 ($ MILLION)

 

LIST OF FIGURE:

  1. APAC CRISPR MARKET BY ACADEMIC INSTITUTIONS 2015-2024 ($ MILLION)
  2. APAC CRISPR MARKET BY BIOTECHNOLOGY COMPANIES 2015-2024 ($ MILLION)
  3. APAC CRISPR MARKET BY PHARMACEUTICAL COMPANIES 2015-2024 ($ MILLION)
  4. APAC CRISPR MARKET BY RESEARCH & DEVELOPMENT INSTITUTES 2015-2024 ($ MILLION)
  5. APAC CRISPR MARKET BY CELL LINE ENGINEERING 2015-2024 ($ MILLION)
  6. APAC CRISPR MARKET BY CRISPR PLASMID 2015-2024 ($ MILLION)
  7. APAC CRISPR MARKET BY GENETIC ENGINEERING 2015-2024 ($ MILLION)
  8. APAC CRISPR MARKET BY GENETICALLY MODIFIED ORGANSIMS & CROPS 2015-2024 ($ MILLION)
  9. APAC CRISPR MARKET BY GENOME EDITING 2015-2024 ($ MILLION)
  10. APAC CRISPR MARKET BY GENE DATABASE/LIBRARY 2015-2024 ($ MILLION)
  11. APAC CRISPR MARKET BY HUMAN STEM CELLS 2015-2024 ($ MILLION)
  12. APAC CRISPR MARKET BY DESIGN TOOLS 2015-2024 ($ MILLION)
  13. APAC CRISPR MARKET BY PLASMID & VECTORS 2015-2024 ($ MILLION)
  14. APAC CRISPR MARKET BY CAS 9 NUCLEASE & GRNA 2015-2024 ($ MILLION)
  15. APAC CRISPR MARKET BY DELIVERY SYSTEM 2015-2024 ($ MILLION)
  16. CHINA CRISPR MARKET 2015-2024 ($ MILLION)
  17. INDIA CRISPR MARKET 2015-2024 ($ MILLION)
  18. KOREA CRISPR MARKET 2015-2024 ($ MILLION)
  19. JAPAN CRISPR MARKET 2015-2024 ($ MILLION)
  20. AUSTRALIA CRISPR MARKET 2015-2024 ($ MILLION)
  21. THAILAND CRISPR MARKET 2015-2024 ($ MILLION)
  22. REST OF ASIA PACIFIC CRISPR MARKET 2015-2024 ($ MILLION)

 

Name

Email

Phone

Company Name

Country

Report Title